Skip to main content
Val Lowe, MD, Nuclear Medicine, Rochester, MN

ValJLoweMD

Nuclear Medicine Rochester, MN

Professor, Radiology, Mayo Medical School

Join Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Join Doximity

Already have an account?

  • Office

    200 1st St Sw
    Rochester, MN 55905
    Phone+1 507-284-2511

Summary

  • Dr. Val Lowe, MD is a board certified nuclear medicine physician in Rochester, Minnesota. He is currently licensed to practice medicine in Minnesota, Florida, and Georgia. He is a Professor at Mayo Medical School.

Education & Training

  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1988

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2013 - 2027
  • AZ State Medical License
    AZ State Medical License 2001 - 2026
  • UT State Medical License
    UT State Medical License 1989 - 2026
  • MN State Medical License
    MN State Medical License 1999 - 2025
  • WI State Medical License
    WI State Medical License 2013 - 2025
  • IA State Medical License
    IA State Medical License 2013 - 2023
  • GA State Medical License
    GA State Medical License 2013 - 2016
  • Nuclear Medicine
    American Board of Nuclear Medicine Nuclear Medicine
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Meet Mukesh Pandey, Ph.D. – Developing a New Drug to Detect Prostate Cancer in Its Earliest Stages
    Meet Mukesh Pandey, Ph.D. – Developing a New Drug to Detect Prostate Cancer in Its Earliest StagesSeptember 23rd, 2019
  • Surgical Planning for Head and Neck Cancer Benefits from FDG-PET/CT
    Surgical Planning for Head and Neck Cancer Benefits from FDG-PET/CTAugust 7th, 2019
  • Game Changers: Five Innovative Tests for Cancer Detection
    Game Changers: Five Innovative Tests for Cancer DetectionSeptember 21st, 2017
  • Join now to see all

Grant Support

  • Amyloid beta peptides and type-2 diabetes sequelae synergistically inhibit insulin signaling and trafficking at the blood brain barrierUNIVERSITY OF MINNESOTA2022–2027
  • Tau PET/CT for Early Detection of Alzheimer’s Disease PathologyMAYO CLINIC ROCHESTER2021–2026